Critic at Large

» cancer

Most Recent

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.


image: Pet Scans

Pet Scans

By Timothy M. Fan, Amy K. LeBlanc, and Nicola Mason | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.


image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By Dean Ho | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.


image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By Tomasz M. Beer | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.


image: Imagining a Cure

Imagining a Cure

By Nicholas P. Restifo and Megan Bachinski | April 11, 2011

For cancer patients, close is not good enough.


Popular Now

  1. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  2. University of Oregon Erecting a $1-Billion Science Center
  3. Could Rapamycin Help Humans Live Longer?
  4. Investigation Finds Signs of Misconduct in Swedish Researcher’s Papers